Asthma is one of the most prevalent chronic health conditions in Canadian children. The 1998--1999 National Population Health Survey found that the prevalence of physician-diagnosed asthma is 8.4% among the whole population and 10.7% among children and teenagers, corresponding to approximately 845,000 children ([@b11-ehp-117-668]). Asthma compromises the quality of life for patients and their families and imposes a burden on the nation's health care expenditure. In 1990, the economic costs of asthma for Canada were estimated to fall between \$504 and \$648 million ([@b31-ehp-117-668]).

Epidemiologic studies have shown that air pollution is associated with asthma-related increases in hospital admissions ([@b9-ehp-117-668]; [@b50-ehp-117-668]), emergency department visits ([@b45-ehp-117-668]; [@b46-ehp-117-668]; [@b48-ehp-117-668]), and respiratory symptoms ([@b8-ehp-117-668]; [@b47-ehp-117-668]), and decreases in pulmonary function ([@b14-ehp-117-668]; [@b20-ehp-117-668]). However, there is a dearth of information about whether these associations can be attributed to lung tissue injury in an asthmatic population, partly because of the lack of appropriate non-invasive biomarkers indicating lung inflammation and tissue injury. In recent years, some researchers have used fractional exhaled nitric oxide (Fe~NO~) to investigate the relationship between exposure to air pollutants and airway inflammation ([@b15-ehp-117-668]; [@b34-ehp-117-668]).

Measurements of mediators in exhaled breath condensate have been used to better understand the pathological mechanisms of airway diseases such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis ([@b26-ehp-117-668]; [@b36-ehp-117-668]). Recently, analysis of mediators in condensed breath has been extended to include lung diseases caused by occupational exposure ([@b33-ehp-117-668]; [@b41-ehp-117-668]). Asthma is a chronic airway inflammatory disease involving a variety of inflammatory cell types and proinflammatory mediators. Reactive oxygen species are also thought to play an active role in inducing airway inflammation and hyperresponsivness ([@b27-ehp-117-668]). Reactive oxygen species result from an increased burden of exogenous oxidants, endogenous lipid peroxidation, as well as from inflammatory cells ([@b24-ehp-117-668]). The level of reactive oxygen species in the airways can be determined by assaying concentrations of oxidative stress markers in breath condensate ([@b26-ehp-117-668]).

We designed this longitudinal study to test the hypothesis that an acute increase in ambient air pollutants is associated with increased levels of markers of oxidative stress and inflammation in breath condensate of children with asthma, and that changes of breath markers are consistent with changes in pulmonary function and Fe~NO~.

Materials and Methods
=====================

Study subjects
--------------

The study protocol was approved by the Research Ethics Board of Health Canada. The parent of each child gave written informed consent before the child's participation in this study.

The study was conducted between October and December of 2005 in Windsor, Ontario, Canada. Asthmatic children, 9 to 14 years of age, from nonsmoking households, were identified from a questionnaire survey of grades one to eight of elementary schoolchildren whose parents were asked whether or not the child had doctor-diagnosed asthma. The parents who gave a positive response were telephoned to confirm the child's current status of doctor-diagnosed asthma and whether there was any smoking of tobacco products in the household. One hundred eighty two subjects agreed to participate in this longitudinal study. Information on family income and family asthma history was extracted from the survey questionnaire. For logistical purposes, children were studied in two test periods, either between 11 October and 11 November (95 children), or between 14 November and 9 December 2005 (87 children). We did not advise parents to alter their children's daily activity and the use of asthma medications.

Ambient air pollution monitoring
--------------------------------

Hourly measures of particulate matter ≤ 2.5 μm in aerodynamic diameter (PM~2.5~), sulfur dioxide, nitrogen dioxide, and ozone were available from the National Air Pollution Surveillance network of Environment Canada (<http://www.etc-cte.ec.gc.ca/NapsData>). There were two monitoring stations representing Windsor, located upwind from the prevailing winds. Of 182 participating children, 180 of them lived within a 10-km radius from the air monitoring sites, and one lived 12 km and another 17 km from the air sampling sites ([Figure 1](#f1-ehp-117-668){ref-type="fig"}). Values from these two monitors were averaged. SO~2~ was measured using ultraviolet fluorescence and the electrical conductivity from changes in chemical composition of a bromine solution, NO~2~ measured using chemiluminescence, O~3~ measured using ultraviolet absorbance, and PM~2.5~ measured using tapered element oscillating microbalance monitor. Pollutant concentrations were averaged over a 24-hr period.

Measurement of spirometry and Fe~NO~
------------------------------------

Once a week, registered respiratory technologists visited the children's schools, and conducted tests of spirometry and Fe~NO~ and collected exhaled breath condensate on study participants. These tests were run on the same day of the week for each child.

Spirometry was performed according to American Thoracic Society criteria ([@b1-ehp-117-668]). KoKo Spirometers (Ferraris CardioRespiratory; Pulmonary Data Services, Inc. Louiseville, CO, USA) were calibrated daily and results adjusted for temperature and barometric pressure. A maximum of eight forced vital capacity (FVC) maneuvers were carried out in an attempt to achieve three acceptable flow-volume loops and two being within 0.20 L for FVC and forced expiratory volume in one second (FEV~1~), and within 0.20 L/sec for the mean forced expiratory flow between 25% and 75% of the FVC (FEF~25--75%~). The value assigned to the child was the largest acceptable value within 200 mL of a second value.

Single-breath on-line measures of Fe~NO~ were carried out according to American Thoracic Society and European Respiratory Society Guidelines ([@b2-ehp-117-668]) using an Eco Physics CLD AL MED chemiluminescence analyzer (Eco Medics AG, Duernten, Switzerland). Before performing a slow vital capacity maneuver over at least 6 sec at 0.05 L/sec, subjects took three tidal volume breaths through a DENOX 88 (Eco Medics AG, Duernten, Switzerland) which contains an NO~x~ absorber cartridge to scrub the ambient air to a value of between 0 and 1.5 ppb. The test was repeated a maximum of eight times in an attempt to obtain at least two acceptable plateau Fe~NO~ values within 10%. The value assigned to the subject was the mean of the two values. We calculated Fe~NO~ statistics using spiroWare 88 software (Eco Medics AG, Duernten, Switzerland).

Collection of exhaled breath condensate, and measurement of amylase, oxidative stress, and inflammation
-------------------------------------------------------------------------------------------------------

Exhaled breath condensate was collected using an RTube (Respiratory Research Inc., Charlottesville, VA, USA). Participants sat and breathed at tidal volumes orally into a mouthpiece attached to a cold condenser, for 10 min. Approximately 1 mL of breath condensate was collected. The condensed breath was then transferred into a microtube and stored at −20°C and then −80°C until use.

To determine saliva contamination, we measured α-amylase activity in breath condensate using an assay kit (Pointe Scientific, MI, USA), which follows the increase in absorbance at 405 nm as the artificial substrate 2-chloro-*p*-nitrophenyl-α-[d]{.smallcaps}-maltotrioside is hydrolyzed.

Thiobarbituric acid reactive substances (TBARS) were determined in duplicate by a fluorescence method adapted from [@b51-ehp-117-668]. We used malonaldehyde bis-(dimethyl acetal) (Aldrich Chemical Co., Milwaukee, WI, USA) to construct a standard curve. To reduce the background interference with the very low levels of TBARS present in exhaled breath condensates, all glassware was washed in soap-free detergent followed by rinsing with distilled water and ethanol before use. We used butanol (OmniSolv, 99.95%; EM Science, Darmstadt, Germany) for extraction. The *n*-butanol extract was transferred to a Whatman glass bottom microplate (Whatman, NJ, USA), previously washed with ethanol, and the fluorescence measured at 530 nm/590 nm, excitation/emission, with a Cytofluor 2350 reader (Millipore, Billerica, MA, USA). The detection limit was 0.02 μM (three times the standard deviation above the blank). The within-run coefficient of variation was 8%.

A colorimetric enzyme immunoassay kit (Cayman Chemical, Ann Arbor, MI, USA) was used to measure 8-isoprostane concentrations in breath condensate. The assays were done in triplicate. A modified standard curve for 8-isoprostane was established for concentrations between 0.975 and 62.5 pg/mL. We were able to detect 8-isoprostane at a concentration as low as 0.975 pg/mL (three times the standard deviation above the blank). The within-run coefficient of variation was 5%. We also measured 8-isoprostane on 8 random samples using radioimmunoassay, a procedure previously described by [@b39-ehp-117-668], and compared the results from both methods \[see Supplemental Material, [Table 1](#t1-ehp-117-668){ref-type="table"} (available online at <http://www.ehponline.org/members/2008/11813/suppl.pdf>)\]. Pearson correlation coefficient for results from two methods was 0.744 (*p* = 0.055), with a mean positive bias of approximately 35% in favor of the radioimmunoassay. Such a difference may be attributed to variations in the avidity and specificity of the antibodies used and the inherent variation during extrapolation from calibration curves at very low levels that were typical of exhaled breath condensates.

We determined the level of interleukin-6 (IL-6) using an ELISA kit from R&D Systems (Minneapolis, MN, USA). We conducted the ELISA assays in duplicate by following manufacturer's instructions accompanying the kit. The detection limit was 0.48 pg/mL.

Statistical analysis
--------------------

We analyzed the correlations among environmental factors, daily use of inhaled corticosteroids (ICS) or short-acting β-agonist (SABA), and testing period, using Spearman rank order correlation, because some variables were not normally distributed. We used mixed-effects regression models to account for repeated measures and to analyze the associations between pollutants and health end points, assuming random slope and random intercepts, and accounting for intraindividual correlation using S-PLUS (version 6.1; Insightful Corporation, Seattle, WA, USA). Data for Fe~NO~, TBARS, and 8-isoprostane were log-transformed to fit a normal distribution. Because \> 99% of the samples gave a value \> 0 for TBARS and 8-isoprostane, and most of them were above the detection limit, data points below the detection limit were not given special treatment. For exposure variables, we tested models for multiday moving averages to examine potentially delayed response. Models were adjusted for time-dependent covariates that were statistically associated with either the exposure or response. We adjusted for testing period (as an indicator variable) to reduce the impact of seasonality. We also included product terms for the interaction of pollutant concentrations with sex and with the use of ICS to test potential modifying effects of sex and ICS. Since subjects served as their own control, we did not adjust for factors which remained constant during the study period such as age, race, family income, and family asthma history. Because health testing was kept on the same day of week for each child, we did not adjust for the effect of day-of-week in the models.

When interactions were detected between pollutants and sex or the use of ICS, the participants were stratified for further analyses. We also ran two-pollutant models to adjust for potential confounding effects of co-pollutants. Results were expressed as percent change in FEV~1~, FEF~25--75%~, Fe~NO~, TBARS and 8-isoprostane per increase in inter-quartile-range concentration of a pollutant. A two-tailed value of *p* ≤ 0.05 was considered statistically significant.

Results
=======

A total of 182 asthmatic children participated in the study, for a total of 691 spirometry test results, 672 Fe~NO~ test results, and 616 breath samples. Seven children had 5 measurement days, 142 had 4 days, 27 had 3 days, and 6 had 2 days. In total, there were 39 measurement days during the study period, and no missing day for air monitoring to match health testing days. The characteristics of this cohort are presented in [Table 1](#t1-ehp-117-668){ref-type="table"}. We measured the concentration of amylase in 25% of breath samples to determine saliva contamination. The median amylase concentration was 0.60 unit/L, with the 95th percentile being 1.46 unit/L. None of the samples had amylase concentrations near the reported salivary amylase concentration of 1,250 unit/L ([@b7-ehp-117-668]). We estimated that saliva contamination was likely \< 0.1%, and therefore interference of breath analysis by saliva was negligible. In 616 breath samples, only 2 samples had detectable IL-6 levels. We therefore did not conduct further analysis on IL-6.

The environmental conditions and daily concentrations of air pollutants measured during the study period are presented in [Table 2](#t2-ehp-117-668){ref-type="table"}. Because Spearman rank order correlation analyses showed that daily temperature, relative humidity and testing period were significantly correlated with some of the pollutants ([Table 3](#t3-ehp-117-668){ref-type="table"}), we included these variables in models to adjust for any confounding/modifying effects. We also included daily use of SABA and ICS to adjust for their potential confounding effects. Because pollutants were correlated with each other ([Table 3](#t3-ehp-117-668){ref-type="table"}), we also ran two-pollutant models to adjust for confounding.

Results from single-pollutant regression models
-----------------------------------------------

[Table 4](#t4-ehp-117-668){ref-type="table"} presents percentage changes of health end points in relation to an increase in interquartile range concentrations of pollutants in a single-pollutant model which also included interaction terms of ICS and sex with pollutants. FEV~1~ and FEF~25--75%~ exhibited a consistent trend of negative associations with all four pollutants, with FEF~25--75%~ having a statistically significant association with NO~2~ and PM~2.5~. The significant associations for FEF~25--75%~ persisted for at least 3 days. Fe~NO~ had a trend of positive associations with SO~2~, NO~2~, and PM~2.5~, but the associations were not statistically significant. Fe~NO~ had a statistically significant negative association with O~3~. TBARS was significantly positively associated with SO~2~, NO~2~, and PM~2.5~, but not with O~3~. The associations for TBARS persisted for at least 3 days. 8-Iso-prostane was significantly positively associated with same-day SO~2~, but not associated with other pollutants.

Modifying effects by the use of ICS and sex
-------------------------------------------

Product terms between pollutants and the use of ICS showed significant interactions for some of the health end points. For example, the product term for SO~2~ and ICS was positively associated with TBARS (*p* = 0.04), but negatively associated with FEV~1~ (*p* \< 0.01), FEV~25--75%~ (*p* = 0.02), and 8-isoprostane (*p* = 0.01), indicating that the use of ICS was a significant effect modifier. The participants were then stratified by the use of ICS during the study period to adjust for modifying effects of use of ICS ([Figure 2](#f2-ehp-117-668){ref-type="fig"}). Children who did not use ICS appeared to have larger risk estimates for pollutants than did those who used ICS. Among children not taking ICS, risk estimates for pollutants were statistically significant with respect to FEV~1~, FEF~25--75%~, and TBARS. Risk estimates for Fe~NO~ and 8-isoprostane were not very different between the two groups of children (data not shown).

Product terms for pollutants and sex showed no significant interaction (*p* \> 0.05), suggesting that sex was not a significant modifier for the associations between air pollutants and health end points. We therefore did not run further analysis on boys and girls separately.

Results from two-pollutant models
---------------------------------

Because we found consistent associations with pollutants for FEV~1~, FEF~25--75%~, Fe~NO~, and TBARS, we ran two-pollutant models on these end points to adjust for confounding effects of co-pollutants ([Figure 3](#f3-ehp-117-668){ref-type="fig"}). For FEV~1~ and FEF~25--75%~, although two-pollutant models did not result in marked changes in risk estimates for PM~2.5~ and O~3~, including PM~2.5~ in models did somewhat change risk estimates for SO~2~ and NO~2~, suggesting that the effects of SO~2~ and NO~2~ on pulmonary function were influenced by PM~2.5~. For Fe~NO~ and TBARS, including two pollutants in models did not markedly change the regression results, suggesting that the results of each pollutant were independent of other pollutants.

Discussion
==========

Principal findings of this study are that SO~2~, NO~2~, and PM~2.5~ in ambient air were significantly associated with decrements in FEV~1~ and FEF~25--75%~, and increases in TBARS in breath condensate among children with asthma. The risk estimates were larger for pollutant concentrations averaged over 3 days than over a shorter term. Clinically FEF~25--75%~ has been considered to be sensitive in detecting small airway dysfunction ([@b32-ehp-117-668]). These associations were robust after inclusion of daily temperature, relative humidity, study period, and the use of asthma medications SABA and ICS in models. The associations for O~3~ and PM~2.5~ were not sensitive to inclusion of co-pollutants, as adjusting for other pollutants in the model did not markedly change the strength of the risk estimates for O~3~ and PM~2.5~. The associations between pulmonary function decrements and SO~2~ and NO~2~ were sensitive to the inclusion of PM~2.5~ in models, suggesting that PM~2.5~ may have confounded some of the effects of SO~2~ and NO~2~. Adverse changes in FEF~25--75%~ were consistent with those of TBARS in response to SO~2~, NO~2~, and PM~2.5~ with a similar lag structure, suggesting a coherent outcome for small airway function and oxidative stress. Our results on pulmonary function changes were similar to those published previously ([@b14-ehp-117-668]; [@b18-ehp-117-668]; [@b20-ehp-117-668]; [@b44-ehp-117-668]), although air pollutant levels in the present study were low compared to those studies.

Exhaled breath condensate has been used in clinical settings to study pathological mechanisms of respiratory illness such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis ([@b5-ehp-117-668]; [@b26-ehp-117-668]). Elevated concentrations of oxidant nitrate ([@b3-ehp-117-668]), IL-6 and leukotriene B4 ([@b12-ehp-117-668]), and 8-isoprostane ([@b37-ehp-117-668]), have been found in breath condensate of adult smokers. Markers of inflammation and oxidative stress in breath were associated with occupational exposure to cobalt and tungsten ([@b21-ehp-117-668]), chromium ([@b10-ehp-117-668]), silica ([@b41-ehp-117-668]), and asbestos ([@b33-ehp-117-668]). [@b38-ehp-117-668] exposed healthy nonsmoking adults to high concentration of O~3~ (400 ppb) and clean air for 2 hr on separate occasions in a laboratory setting, and reported that exposure to O~3~ led to a significant increase in 8-isoprostane concentrations in breath condensate. [@b6-ehp-117-668] exposed adult human subjects to wood smoke in a controlled environment and reported an increase in malondialdehyde levels in breath for at least 20 hr postexposure. However, little work has been done to use biomarkers in breath condensate to examine the effects of ambient air pollutants on airway inflammation and oxidative stress among asthmatic children. Very recently, [@b18-ehp-117-668] reported a cohort study on 12- to 18-year-old male healthy and asthmatic students in a New Zealand boarding school, where they found small effects of PM~10~ (PM with aerodynamic diameter \< 10 μm) in ambient air on FEV~1~, but no effect on pH and hydrogen peroxide in exhaled breath. However, with a panel of asthmatic children living in Mexico City, Romieu et al. found an association between malondialdehyde in exhaled breath and PM~2.5~ and O~3~ in ambient air ([@b44-ehp-117-668]). A 14.2-μg/m^3^ (interquartile-range) increase in 8-hr moving average PM~2.5~ was significantly associated with a 1.12-nmol increase in malondialdehyde, while a 15.9-ppb (inter-quartile-range) increase in 8-hr moving average O~3~ was significantly associated with a 1.16-nmol increase in malondialdehyde. Our results are consistent with these findings in that inhaled ambient air pollutants were significantly associated with an increase in an oxidative stress marker in breath condensate.

Oxidative stress--inducing reactive oxygen species are physiologically active mediators that can be induced by air pollutants. PM~2.5~, SO~2~, NO~2~, and O~3~ have been demonstrated to cause formation of excessive amount of reactive oxygen species in airways and in the cardiovascular system in experimental animals, leading to tissue inflammation and cell death ([@b17-ehp-117-668]; [@b35-ehp-117-668]; [@b42-ehp-117-668]). Oxidative stress has been linked to clinical phenotypes such as asthma and atherosclerosis ([@b13-ehp-117-668]; [@b49-ehp-117-668]). TBARS are a group of low-molecular-weight chemicals that are formed during the decomposition of lipid peroxidation products ([@b22-ehp-117-668]), and thus are often used as an index of lipid peroxidation and oxidative stress ([@b30-ehp-117-668]; [@b43-ehp-117-668]; [@b49-ehp-117-668]). 8-Isoprostane is a prostaglandin F2α--like compound produced by free radicals via the nonenzymatic peroxidation of arachidonic acid in membrane phospholipids ([@b40-ehp-117-668]). Because TBARS are derived from oxidative degradation of a broader range of biological substances including lipids and sugars than is 8-isoprostane ([@b23-ehp-117-668]; [@b28-ehp-117-668]), and because we observed an increase in TBARS but not 8-isoprostane in breath samples in relation to elevated air pollutants, it appears that TBARS may be a more sensitive biomarker than 8-iso-prostane in breath condensate as a useful tool for investigating air pollution-related oxidative stress among asthmatic children, especially for acute exposures. It remains to be seen whether immunoassays with significantly higher sensitivity and specificity can improve the efficacy of 8-isoprostane as a biomarker of oxidative stress in exhaled breath condensate.

ICS are thought to reduce inflammation and oxidative stress in airways ([@b5-ehp-117-668]; [@b29-ehp-117-668]). Children with asthma exacerbation have reduced 8-isoprostane in breath condensate after ICS treatment ([@b5-ehp-117-668]). In the present study, we found that ICS seems to be able to reduce some of the adverse effects of air pollutants, as the risk estimates appear to be larger for the children who did not take ICS during the study period. Consistent with our findings, previous studies have also reported stronger associations between exposure to air pollutants and decrements in pulmonary function and increases in Fe~NO~ for children not taking anti-inflammatory medications than for children taking the medications ([@b15-ehp-117-668], [@b16-ehp-117-668]; [@b34-ehp-117-668]). In the present study only 37% of children used ICS, which could result in a reduced statistical power to detect associations with pollutants in this group.

Oxidative stress often occurs along with tissue inflammation, which induces the release of reactive oxygen species to cause tissue injury ([@b13-ehp-117-668]; [@b17-ehp-117-668]; [@b30-ehp-117-668]). Unlike previously published studies ([@b15-ehp-117-668]; [@b34-ehp-117-668]), in our study we did not find statistically significant adverse changes in inflammatory marker Fe~NO~ associated with air pollution, and the level of IL-6 in breath condensate was too low to be detectable. One interpretation for the results of inflammation markers was that we might need a larger sample size to detect significant changes in airway inflammation. Another possible explanation might be that the inflammation in lower airways of the children was not captured by Fe~NO~ measured at a flow rate of 0.05 L/sec; [@b6-ehp-117-668] reported that exposure to wood smoke particles resulted in significant increase in Fe~NO~ measured at a flow rate of 0.27 L/sec, but not at 0.05 L/sec. Alternatively, this group of asthmatic children might have been in such a state of airway inflammation that it overwhelmed the effects of air pollution, particularly when exposure concentrations were lower than those in other studies ([@b15-ehp-117-668]; [@b34-ehp-117-668]).

We did not find a consistent adverse effect of O~3~. O~3~ exhibited a significantly negative association with Fe~NO~ ([Table 4](#t4-ehp-117-668){ref-type="table"}), but a positive association with TBARS ([Figure 3](#f3-ehp-117-668){ref-type="fig"}). The negative association between O~3~ concentration and Fe~NO~ is counterintuitive, because laboratory studies have shown that O~3~ at high concentrations (200--400 ppb) caused inflammation in the airways of human subjects ([@b4-ehp-117-668]; [@b19-ehp-117-668]). In the present study, adjusting for co-pollutants and study periods in the models did not change the results. A sound interpretation for this result remains to be found at this point in time.

When a large number of regression models are run on a data set, some statistically significant associations may occur by chance. To reduce the possibility of spurious relationships due to multiple comparisons, we limited sensitivity analyses to those that consistently demonstrated statistical significance in base models, and considered only results showing a consistent pattern as actual effects.

Conclusion
==========

Results from our study demonstrate a significant decrement in small airway function and an increase in airway oxidative stress in asthmatic children in association with SO~2~, NO~2~, and PM~2.5~ in ambient air. TBARS in breath condensate may be a useful tool for investigating air pollution-related oxidative stress among asthmatic children. ICS seems to be able to reduce some of the adverse respiratory response to air pollutants.

Supplemental Material is available online at <http://www.ehponline.org/members/2008/11813/suppl.pdf>
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###### 

Selected characteristics of 182 asthmatic children from Windsor, Ontario, Canada.

  Characteristic                                                                                                     Value
  ------------------------------------------------------------------------------------------------------------------ --------------------
  Age (years) \[median (range)\]                                                                                     11 (9--14)
  Sex \[no. (%)\]                                                                                                    
   Female                                                                                                            68 (37.4)
   Male                                                                                                              114 (62.6)
  Race \[no. (%)\]                                                                                                   
   Caucasian                                                                                                         160 (87.9)
   Other                                                                                                             22 (12.1)
  Parental asthma \[no. (%)\]                                                                                        
   No                                                                                                                11 (6.0)
   Yes                                                                                                               70 (38.5)
   Unknown                                                                                                           101 (55.5)
  Self-reported medication use[a](#tfn1-ehp-117-668){ref-type="table-fn"} \[no. (%)\]                                
   ICS                                                                                                               68 (37.4)
   SABA                                                                                                              64 (35.2)
   Other asthma medications                                                                                          33 (18.1)
   None                                                                                                              77 (42.3)
  FEV~1~ (L) \[median (5th-- 95th percentile)\]                                                                      2.4 (1.7--3.3)
  Percent predicted FEV~1~ (%) \[median (5th-- 95th percentile)\][b](#tfn2-ehp-117-668){ref-type="table-fn"}         90.5 (68.6--107.1)
  FEF~25--75%~ (L/sec) \[median (5th-- 95th percentile)\]                                                            2.5 (1.3--3.9)
  Percent predicted FEF~25--75%~ (%) \[median (5th-- 95th percentile)\][b](#tfn2-ehp-117-668){ref-type="table-fn"}   78.2 (45.3--118.0)
  Fe~NO~ (ppb) \[median (5th-- 95th percentile)\]                                                                    19.4 (4.5--81.6)
  TBARS (μM) \[median (5th-- 95th percentile)\]                                                                      0.26 (0.03--1.53)
  8-Isoprostane (pg/mL) \[median (5th-- 95th percentile)\]                                                           1.43 (0.30--4.20)

More than one medication could be used.

Predicted normal values were calculated based on a given height, age, sex, and race/ethnicity ([@b25-ehp-117-668]).

###### 

Values for selected environmental conditions during study period.

                          Median \[interquartile range (5th--95th percentile)\]                                 
  ----------------------- ------------------------------------------------------- ----------------------------- -----------------------------
  SO~2~ (ppb)             4.5 \[6.5 (0.5 to 15.5)\]                               5.0 \[5.6 (1.0 to 13.0)\]     5.6 \[5.4 (1.3 to 13.8)\]
  NO~2~ (ppb)             19.8 \[9.8 (9.5 to 29.5)\]                              18.3 \[9.0 (11.3 to 28.0)\]   18.3 \[6.8 (12.3 to 27.0)\]
  O~3~ (ppb)              13.0 \[9.0 (6.5 to 26.5)\]                              14.1 \[6.4 (6.8 to 23.3)\]    14.0 \[5.3 (7.5 to 21.0)\]
  PM~2.5~ (μg/m^3^ )      6.5 \[6.0 (2.0 to 19.0)\]                               6.6 \[6.4 (2.0 to 15.0)\]     6.9 \[5.4 (2.7 to 14.3)\]
  Temperature (°C)        6.6 \[13.0 (−7.7 to 15.4)\]                             7.4 \[12.0 (−5.5 to 14.7)\]   7.4 \[11.2 (−5.9 to 14.5)\]
  Relative humidity (%)   67.4 \[11.6 (53.3 to 87.9)\]                            65.6 \[9.7 (54.4 to 75.6)\]   65.7 \[7.3 (54.9 to 74.2)\]

Air quality was monitored between 8 October and 9 December 2005, 62 sampling days.

###### 

Spearman rank order correlation coefficients of variables.

  Variable            Temperature                                         Relative humidity                                  SO~2~                                               NO~2~                                               O~3~                                                PM~2.5~                                             SABA                                                ICS
  ------------------- --------------------------------------------------- -------------------------------------------------- --------------------------------------------------- --------------------------------------------------- --------------------------------------------------- --------------------------------------------------- --------------------------------------------------- ---------------------------------------------------
  Testing period      −0.73[\*](#tfn4-ehp-117-668){ref-type="table-fn"}   0.01                                               0.35[\*](#tfn4-ehp-117-668){ref-type="table-fn"}    −0.30[\*](#tfn4-ehp-117-668){ref-type="table-fn"}   0.06                                                −0.07                                               0.10[\*](#tfn4-ehp-117-668){ref-type="table-fn"}    −0.07
  Temperature                                                             0.18[\*](#tfn4-ehp-117-668){ref-type="table-fn"}   −0.17[\*](#tfn4-ehp-117-668){ref-type="table-fn"}   0.00                                                0.18[\*](#tfn4-ehp-117-668){ref-type="table-fn"}    0.10[\*](#tfn4-ehp-117-668){ref-type="table-fn"}    −0.10[\*](#tfn4-ehp-117-668){ref-type="table-fn"}   −0.02
  Relative humidity                                                                                                          −0.04                                               0.03                                                −0.51[\*](#tfn4-ehp-117-668){ref-type="table-fn"}   0.20[\*](#tfn4-ehp-117-668){ref-type="table-fn"}    0.01                                                −0.02
  SO~2~                                                                                                                                                                          0.18[\*](#tfn4-ehp-117-668){ref-type="table-fn"}    −0.02                                               0.56[\*](#tfn4-ehp-117-668){ref-type="table-fn"}    0.04                                                0.05
  NO~2~                                                                                                                                                                                                                              −0.51[\*](#tfn4-ehp-117-668){ref-type="table-fn"}   0.71[\*](#tfn4-ehp-117-668){ref-type="table-fn"}    −0.04                                               0.07
  O~3~                                                                                                                                                                                                                                                                                   −0.41[\*](#tfn4-ehp-117-668){ref-type="table-fn"}   0.00                                                −0.10[\*](#tfn4-ehp-117-668){ref-type="table-fn"}
  PM~2.5~                                                                                                                                                                                                                                                                                                                                    −0.05                                               0.07
  SABA                                                                                                                                                                                                                                                                                                                                                                                           0.27[\*](#tfn4-ehp-117-668){ref-type="table-fn"}

*p* \< 0.05.

###### 

Percent change (95% confidence interval) in health end points of 182 asthmatic children, in association with an interquartile-range increase of a pollutant, in single--pollutant models with various lag times.

  Air pollutant    FEV~1~               FEF~25--75%~                                                      Fe~NO~                                                              TBARS                                                              8--Isoprostane
  ---------------- -------------------- ----------------------------------------------------------------- ------------------------------------------------------------------- ------------------------------------------------------------------ ----------------------------------------------------------------
  SO~2~                                                                                                                                                                                                                                          
   Same day        −0.3 (−1.3 to 0.7)   −1.0 (−3.1 to 1.3)                                                5.8 (−5.0 to 17.8)                                                  17.4 (0.3 to 37.4)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}     14.1 (2.5 to 26.9)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}
   Lag 1 day       0.1 (−1.1 to 1.2)    −0.9 (−3.1 to 1.4)                                                1.6 (−9.3 to 13.9)                                                  14.1 (−1.8 to 32.5)                                                −2.4 (−11.7 to 7.9)
   2-day average   −0.1 (−1.4 to 1.3)   −1.8 (−4.7 to 1.1)                                                5.9 (−9.3 to 23.7)                                                  35.1 (9.5 to 66.8)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}     9.4 (−5.2 to 26.2)
   3-day average   −0.3 (−1.9 to 1.4)   −2.3 (−5.5 to 1.0)                                                1.7 (−14.1 to 20.3)                                                 61.8 (24.9 to 109.5)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}   −0.3 (−16.4 to 18.9
                                                                                                                                                                                                                                                 
  NO~2~                                                                                                                                                                                                                                          
   Same day        −0.6 (−1.6 to 0.3)   −2.4 (−4.3 to −0.4)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}   8.2 (−2.9 to 20.6)                                                  21.2 (1.9 to 44.2)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}     0.0 (−10.7 to 12.1)
   Lag 1 day       −0.3 (−1.1 to 0.6)   −1.4 (−3.1 to 0.3)                                                3.7 (−6.1 to 14.6)                                                  10.2 (−5.6 to 28.7)                                                −5.6 (−14.8 to 4.5)
   2-day average   −0.6 (−1.6 to 0.4)   −2.4 (−4.3 to −0.3)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}   7.4 (−4.6 to 21.0)                                                  20.3 (−0.4 to 45.3)                                                −4.7 (−1.1 to 8.1)
   3-day average   −0.8 (−1.9 to 0.3)   −2.8 (−5.0 to −0.5)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}   0.5 (−12.1 to 14.9)                                                 32.9 (7.2 to 64.6)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}     −4.0 (−16.3 to 10.2)
                                                                                                                                                                                                                                                 
  O~3~                                                                                                                                                                                                                                           
   Same day        −0.4 (−1.6 to 0.7)   0.2 (−2.1 to 2.5)                                                 −12.2 (−22.3 to −0.8)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}   5.0 (−13.2 to 27.0)                                                7.0 (−6.5 to 22.4)
   Lag 1 day       −0.2 (−1.1 to 0.7)   0.1 (−1.7 to 1.9)                                                 −8.3 (−16.0 to 0.2)                                                 7.3 (−6.7 to 23.4)                                                 6.6 (−3.4 to 17.6)
   2-day average   −0.4 (−1.6 to 0.9)   0.4 (−2.2 to 3.0)                                                 −16.0 (−26.4 to −4.1)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}   14.4 (−8.5 to 43.0)                                                12.0 (−3.8 to 30.5)
   3-day average   −0.5 (−2.0 to 1.0)   −0.4 (−3.5 to 2.7)                                                −1.6 (−16.7 to 16.1)                                                8.8 (−17.4 to 43.4)                                                15.9 (−3.5 to 39.1)
                                                                                                                                                                                                                                                 
  PM~2.5~                                                                                                                                                                                                                                        
   Same day        −0.5 (−1.3 to 0.3)   −1.9 (−3.5 to −0.3)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}   5.3 (−3.6 to 15)                                                    16.9 (2.2 to 33.6)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}     5.1 (−3.6 to 14.5)
   Lag 1 day       −0.3 (−1.1 to 0.5)   −1.2 (−2.8 to 0.3)                                                1.7 (−6.3 to 10.4)                                                  14.6 (0.8 to 30.4)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}     −3.8 (−12.1 to 5.3)
   2-day average   −0.6 (−1.5 to 0.4)   −2.0 (−3.8 to −0.2)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}   4.3 (−5.4 to 15.1)                                                  22.0 (4.8 to 42.1)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}     0.1 (−9.8 to 11.1)
   3-day average   −1.1 (−3.1 to 0.9)   −3.3 (−7.2 to 0.8)                                                −17.3 (−33.5 to 2.9)                                                69.1 (20.1 to 138.2)[\*](#tfn6-ehp-117-668){ref-type="table-fn"}   5.8 (−15.8 to 33.0)

2-day average: the median concentration of a pollutant collected on the day and 1 day before the clinical testing was done. 3-day average: the median concentration of a pollutant collected on the day and 2 days before the clinical testing was done. Models were adjusted for testing period, daily temperature, relative humidity, and use of SABA and ICS. Interaction terms were included in the models to test modifying effects of taking ICS (a binary indicator) and sex (binary indicator) on air pollutants.

*p* \< 0.05.
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